Status:
UNKNOWN
Pain Processing In Relation To Breathing
Lead Sponsor:
Balgrist University Hospital
Conditions:
Central Sensitisation
Pain
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the effect of breathing on the processing of experimental pain in healthy participants. The main questions are: 1. Does breathing rate influence the ...
Eligibility Criteria
Inclusion
- over 18 and below 40 years of age
- good general health
- able to give informed consent
Exclusion
- any major medical or psychiatric condition (e.g. heart disease, diabetes, autoimmune disorders, infectious diseases, major depressive disorder), any chronic pain condition, any respiratory problems, any current acute pain at time of study
- inability to follow study instructions, e.g. due to language problems
- Consumption of alcohol, drugs, analgesics within the last 24 h
- Consumption of no more than 100 mg of caffeine within the last 8 h
- Scar tissue or generally reduced sensitivity in the designated testing site areas
- Additional exclusion criteria for experiments 3 and 4
- Shoe size \< 38
- Restless-Legs-Syndrome
Key Trial Info
Start Date :
May 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06169917
Start Date
May 14 2023
End Date
May 31 2025
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Balgrist, University Zürich
Zurich, Switzerland, 8008